Post by Department of Cardiovascular Surgery, TUM University Hospital German Heart Center

🎉 Mitral valve repair continues to demonstrate excellent durability, even in complex cases.   💕 A multicenter, randomized trial of patients with degenerative mitral regurgitation (DMR) and concomitant tricuspid valve disease revealed the following: • 92% survival rate, free from reoperation or severe MR, at two years • Very low recurrence rate of severe MR (1.4%) • Higher risk of failure in anterior or bileaflet pathology   🚨 Key takeaway: Mitral valve (MV) repair remains a highly effective and durable strategy, providing a strong benchmark for current practice.   🔗 Link: https://lnkd.in/eMTBurUr Michael Chu, Samantha Raymond, Annetine Gelijns, Moskowitz Alan, Michael Borger, Mike Mack, Judy Hung, Pierre Voisine, James Gammie, Prof. Dr. med. Markus Krane, Babatunde Yerokun, Michael Bowdish, Lenard Conradi, Steven F. Bolling, Wendy Taddei-Peters, Neal O. Jeffries, Mary E. Marks, Lopa Gupta, Alexander Iribarne, MD, MS, Friedhelm Beyersdorf, Emilia Bagiella, Arnar Geirsson, Jessica R. Overbey, Marc Gillinov, Patrick OGara, Gorav Ailawadi, MD, MBA, Volkmar Falk, TUM Klinikum Deutsches Herzzentrum, JACC Journals